Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP455519.RAZ2ywARDpdNeBe8Vw0ShaRZVYVGcU1zO7dj4RmO8xgMY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP455519.RAZ2ywARDpdNeBe8Vw0ShaRZVYVGcU1zO7dj4RmO8xgMY130_assertion type Assertion NP455519.RAZ2ywARDpdNeBe8Vw0ShaRZVYVGcU1zO7dj4RmO8xgMY130_head.
- NP455519.RAZ2ywARDpdNeBe8Vw0ShaRZVYVGcU1zO7dj4RmO8xgMY130_assertion description "[MDR1/P-gp and MRP2 might have some additional predictive value for the clinical outcome of patients with advanced ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455519.RAZ2ywARDpdNeBe8Vw0ShaRZVYVGcU1zO7dj4RmO8xgMY130_provenance.
- NP455519.RAZ2ywARDpdNeBe8Vw0ShaRZVYVGcU1zO7dj4RmO8xgMY130_assertion evidence source_evidence_literature NP455519.RAZ2ywARDpdNeBe8Vw0ShaRZVYVGcU1zO7dj4RmO8xgMY130_provenance.
- NP455519.RAZ2ywARDpdNeBe8Vw0ShaRZVYVGcU1zO7dj4RmO8xgMY130_assertion SIO_000772 15262134 NP455519.RAZ2ywARDpdNeBe8Vw0ShaRZVYVGcU1zO7dj4RmO8xgMY130_provenance.
- NP455519.RAZ2ywARDpdNeBe8Vw0ShaRZVYVGcU1zO7dj4RmO8xgMY130_assertion wasDerivedFrom befree-20140225 NP455519.RAZ2ywARDpdNeBe8Vw0ShaRZVYVGcU1zO7dj4RmO8xgMY130_provenance.
- NP455519.RAZ2ywARDpdNeBe8Vw0ShaRZVYVGcU1zO7dj4RmO8xgMY130_assertion wasGeneratedBy ECO_0000203 NP455519.RAZ2ywARDpdNeBe8Vw0ShaRZVYVGcU1zO7dj4RmO8xgMY130_provenance.